Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/4646
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSehrawat, Sharvan-
dc.date.accessioned2023-08-12T17:14:59Z-
dc.date.available2023-08-12T17:14:59Z-
dc.date.issued2021-
dc.identifier.citationMicrobes and Infection, 23(1).en_US
dc.identifier.urihttps://doi.org/10.1016/j.micinf.2021.104779-
dc.identifier.urihttp://hdl.handle.net/123456789/4646-
dc.descriptionOnly IISERM authors are available in the record.en_US
dc.description.abstractThe COVID-19 pandemic has raised many issues not the least of which is the reason for its high variability in consequences to the infected person. In this opinion letter, we advocate that the dose and presentation of the infecting virus is a major factor that affects whether the outcome is subclinical, tissue damaging or even lethal following infection. We briefly describe the known effects of virus dose on the course COVID-19 and discuss practical maneuvers as well as largely untested procedures that can raise the threshold dose needed to break through barriers of resistance.en_US
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.subjectCOVID-19en_US
dc.subjectdiseaseen_US
dc.subjectquestionen_US
dc.subjectdoseen_US
dc.titleCOVID-19: disease, or no disease? - that is the question. It’s the dose stupid!en_US
dc.typeArticleen_US
Appears in Collections:Research Articles

Files in This Item:
File Description SizeFormat 
Need To Add…Full Text_PDF..pdfOnly IISERM authors are available in the record.15.36 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.